Tania Simoncelli is vice president of science in society at the Chan Zuckerberg Initiative, which she joined in 2017 with a vision to build a program committed to centering patients in the biomedical research ecosystem. In 2019, she launched the Rare As One Project, a first-of-its-kind program that supports patient communities in their quest to accelerate research. With 20 years of experience in science policy and advocacy, Simoncelli previously held roles at the Broad Institute of MIT and Harvard, the White House Office of Science and Technology Policy, US Food and Drug Administration, and American Civil Liberties Union. In 2013, the journal Nature named her “one of 10 people who mattered” for spearheading the ACLU’s successful Supreme Court case challenging the patenting of human genes.
Previously
At just 37 years old, Brian and Sandra, who met and fell in love on the 2008 Obama campaign, found their world upended by Brian’s diagnosis of ALS and the possibility that he...
Patients, and the networks of people who support them, already play a powerful role in sharpening our understanding of disease, but much more can be done to center their exper...
Fueled by a sense of mission and the recognition that neither government nor the private sector alone can set society on an optimal course, foundations play a unique role in p...
A devastating diagnosis is enough to make anyone despair, but some hardy individuals respond by propelling themselves into action. While many diseases have support groups for...